Please login to the form below

Mereo BioPharma

This page shows the latest Mereo BioPharma news and features for those working in and with pharma, biotech and healthcare.

Celgene says no to Mereo’s cancer drug etigilimab

UK biotech will focus on rare disease drugs. Mereo BioPharma has lost Celgene as a partner for anti-TIGIT drug etigilimab, one of two drugs acquired when Mereo merged with OncoMed ... Ahead of the Mereo merger, it decided not to pursue a project focusing

Latest news

Mereo’s shareholders back OncoMed takeover

Deal expected to go through next week. UK company Mereo BioPharma is on the brink of a US listing, via the takeover of troubled US biotech OncoMed, after the deal was ... After the merger goes through, OncoMed will be a wholly-owned subsidiary of Mereo,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Pharma deals in July 2015

Woodford has also been an investor in the deal whereby Novartis spun off three phase II products for an equity stake in a newly formed company, Mereo Biopharma, which raised $119m. ... It is hoped that Immunocore and Mereo are signs that at long last the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

New hires at Crescendo, Healx and Galecto

Prior to joining Healx, he worked as CMO at Aparito and as therapeutic area head of orphan drugs at Mereo BioPharma.
Mereo BioPharma appoints head of patient access and commercial planning

Wills Hughes-Wilson joins the group from Sobi. London, UK-based Mereo BioPharma, has strengthened its team with the addition of Wills Hughes-Wilson, who joins the biopharma as its new ... Dr Denise Scots-Knight, chief executive officer of Mereo BioPharma,
Mereo BioPharma appoints CFO

Richard Jones joins the rare diseases specialist. London, UK-based Mereo BioPharma Group has appointed Richard Jones as chief financial officer and member of the board of directors, effective from early ... Dr Denise Scots-Knight, chief executive of
Mereo BioPharma’s Richard Bungay to step down

Will leave CFO and COO roles in April 2017. Mereo BioPharma's Richard Bungay is set to step down from his roles as chief financial officer and chief operating officer in ... Bungay joined the UK-based clinical stage biopharmaceutical firm in July last

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa: Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment: International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?: Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...